Inspire Medical Systems Yönetim
Yönetim kriter kontrolleri 4/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Tim Herbert
İcra Kurulu Başkanı
US$7.5m
Toplam tazminat
| CEO maaş yüzdesi | 9.2% |
| CEO görev süresi | 17yrs |
| CEO sahipliği | 1.0% |
| Yönetim ortalama görev süresi | 4.3yrs |
| Yönetim Kurulu ortalama görev süresi | 5.3yrs |
Son yönetim güncellemeleri
Recent updates
Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07
A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)
Oct 31Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?
Oct 03After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar
Aug 08Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?
Jul 17At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?
Jun 22Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors
May 09Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors
Dec 26Inspire Medical Systems: Time To Wake Up
Nov 17An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued
Nov 13Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?
Sep 05Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?
Aug 10Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing
Jul 16Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Jun 15Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching
May 06Inspire Medical stock rises after guiding revenue above estimates
Jan 09CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$33m |
| Jun 30 2024 | n/a | n/a | US$6m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$7m | US$690k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$33m |
| Jun 30 2023 | n/a | n/a | -US$41m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$6m | US$645k | -US$45m |
| Sep 30 2022 | n/a | n/a | -US$50m |
| Jun 30 2022 | n/a | n/a | -US$44m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$1m | US$620k | -US$42m |
| Sep 30 2021 | n/a | n/a | -US$47m |
| Jun 30 2021 | n/a | n/a | -US$47m |
| Mar 31 2021 | n/a | n/a | -US$57m |
| Dec 31 2020 | US$5m | US$506k | -US$57m |
| Sep 30 2020 | n/a | n/a | -US$59m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$41m |
| Dec 31 2019 | US$3m | US$440k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$29m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$24m |
| Dec 31 2018 | US$3m | US$418k | -US$22m |
| Sep 30 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$21m |
| Mar 31 2018 | n/a | n/a | -US$20m |
| Dec 31 2017 | US$600k | US$380k | -US$18m |
Tazminat ve Piyasa: Tim 'ın toplam tazminatı ($USD 7.49M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 7.91M ).
Tazminat ve Kazançlar: Tim 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Tim Herbert (61 yo)
17yrs
Görev süresi
US$7,490,775
Tazminat
Mr. Timothy P. Herbert, also known as Tim, has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007 and has been its Chairman since May 2, 2024. He is t...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 17yrs | US$7.49m | 0.99% $ 51.0m | |
| Chief Financial Officer | 10.5yrs | US$2.30m | 0.10% $ 5.3m | |
| Chief Commercial Officer | 5.8yrs | US$2.26m | 0.0023% $ 120.1k | |
| Chief Medical Officer | 1.3yrs | US$211.35k | 0.0031% $ 161.5k | |
| Chief Strategy Officer | 1.3yrs | US$2.10m | 0% $ 0 | |
| Chief Technology Officer | 2.5yrs | US$2.10m | 0.029% $ 1.5m | |
| Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Senior VP | 3.8yrs | US$2.69m | 0.0044% $ 225.6k | |
| Chief People Officer | less than a year | Veri yok | Veri yok | |
| Senior Vice President of U.S. Sales | 4.8yrs | Veri yok | Veri yok | |
| Executive VP & MD of Europe | 4.8yrs | Veri yok | Veri yok | |
| Director of Financial Reporting | no data | Veri yok | Veri yok |
4.3yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim: INSP 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.3 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 17yrs | US$7.49m | 0.99% $ 51.0m | |
| Independent Director | 16.8yrs | US$235.88k | 0.068% $ 3.5m | |
| Independent Director | 16.3yrs | US$238.38k | 0.069% $ 3.6m | |
| Independent Director | 7.8yrs | US$248.38k | 0.085% $ 4.4m | |
| Independent Director | 4.1yrs | US$243.38k | 0.0060% $ 307.9k | |
| Lead Independent Director | 5.3yrs | US$243.38k | 0.012% $ 616.9k | |
| Independent Director | 4.3yrs | US$238.38k | 0.0050% $ 258.8k | |
| Independent Director | less than a year | US$271.56k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$235.88k | 0.0022% $ 115.4k |
5.3yrs
Ortalama Görev Süresi
65yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: INSP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).